{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:17:56Z","timestamp":1788866276391,"version":"build-2803163510"},"reference-count":60,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1210\/js.2018-00178","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T14:00:49Z","timestamp":1531490449000},"page":"933-943","source":"Crossref","is-referenced-by-count":49,"title":["Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma"],"prefix":"10.1210","volume":"2","author":[{"given":"Friedhelm","family":"Raue","sequence":"first","affiliation":[{"name":"Endocrine Practice Heidelberg, Molecular Genetic Laboratory, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Frank-Raue","sequence":"additional","affiliation":[{"name":"Endocrine Practice Heidelberg, Molecular Genetic Laboratory, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"issue":"3","key":"2019041123160857300_B1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10689-010-9320-2","article-title":"Update multiple endocrine neoplasia type 2","volume":"9","author":"Raue","year":"2010","journal-title":"Fam Cancer"},{"issue":"8","key":"2019041123160857300_B2","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update","volume":"98","author":"Wells","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041123160857300_B3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"6","key":"2019041123160857300_B4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"issue":"7","key":"2019041123160857300_B5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1590\/0004-2730000003427","article-title":"Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism","volume":"58","author":"Maia","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"2","key":"2019041123160857300_B6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00423-013-1139-5","article-title":"Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES)","volume":"399","author":"Niederle","year":"2014","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"2019041123160857300_B7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000346174","article-title":"2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer","volume":"1","author":"Elisei","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"3","key":"2019041123160857300_B8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/thy.2012.0236","article-title":"Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma","volume":"23","author":"Frank-Raue","year":"2013","journal-title":"Thyroid"},{"issue":"6","key":"2019041123160857300_B9","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1210\/jc.2009-2368","article-title":"Biomarker-based risk stratification for previously untreated medullary thyroid cancer","volume":"95","author":"Machens","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041123160857300_B10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1373\/clinchem.2010.151688","article-title":"Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer","volume":"57","author":"Kratzsch","year":"2011","journal-title":"Clin Chem"},{"issue":"9","key":"2019041123160857300_B11","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1373\/clinchem.2016.270009","article-title":"United States and European Multicenter prospective study for the analytical performance and clinical validation of a novel sensitive fully automated immunoassay for calcitonin","volume":"63","author":"Kahaly","year":"2017","journal-title":"Clin Chem"},{"issue":"5","key":"2019041123160857300_B12","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1210\/jc.2014-4508","article-title":"Reference range of serum calcitonin in pediatric population","volume":"100","author":"Castagna","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"2019041123160857300_B13","first-page":"2857","article-title":"[Demonstration of neural origin of calcitonin cells of ultimobranchial body of chick embryo]","volume":"270","author":"Le Douarin","year":"1970","journal-title":"C R Acad Sci Hebd Seances Acad Sci D"},{"issue":"20","key":"2019041123160857300_B14","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1242\/dev.126581","article-title":"Revising the embryonic origin of thyroid C cells in mice and humans","volume":"142","author":"Johansson","year":"2015","journal-title":"Development"},{"issue":"3","key":"2019041123160857300_B15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/dvdy.24377","article-title":"Cellular and molecular events on the development of mammalian thyroid C cells","volume":"245","author":"Kameda","year":"2016","journal-title":"Dev Dyn"},{"issue":"2","key":"2019041123160857300_B16","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1002\/bjs.10746","article-title":"Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations","volume":"105","author":"Machens","year":"2018","journal-title":"Br J Surg"},{"issue":"6","key":"2019041123160857300_B17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/humu.23430","article-title":"Genotype-specific progression of hereditary medullary thyroid cancer","volume":"39","author":"Machens","year":"2018","journal-title":"Hum Mutat"},{"issue":"3","key":"2019041123160857300_B18","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1210\/jc.2010-1234","article-title":"Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d\u2019Etude des Tumeurs Endocrines","volume":"96","author":"Rohmer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123160857300_B19","doi-asserted-by":"crossref","first-page":"T41","DOI":"10.1530\/ERC-17-0202","article-title":"Advances in risk-oriented surgery for multiple endocrine neoplasia type 2","volume":"25","author":"Machens","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2019041123160857300_B20","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1909::AID-CNCR21>3.0.CO;2-A","article-title":"Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis","volume":"88","author":"Machens","year":"2000","journal-title":"Cancer"},{"key":"2019041123160857300_B21","doi-asserted-by":"crossref","unstructured":"Prete\n              FP\n            , Abdel-AzizT, MorkaneC, BrainC, KurzawinskiTR; MEN2 in Children UK Collaborative Group. Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2. Br J Surg. 2018;April 17.","DOI":"10.1002\/bjs.10856"},{"issue":"29","key":"2019041123160857300_B22","doi-asserted-by":"crossref","first-page":"e1108","DOI":"10.1097\/MD.0000000000001108","article-title":"Postoperative complications after prophylactic thyroidectomy for very young patients with multiple endocrine neoplasia type 2: retrospective cohort analysis","volume":"94","author":"Kluijfhout","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2019041123160857300_B23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.surg.2016.03.007","article-title":"Impact of central node dissection on postoperative morbidity in pediatric patients with suspected or proven thyroid cancer","volume":"160","author":"Machens","year":"2016","journal-title":"Surgery"},{"issue":"2","key":"2019041123160857300_B24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041123160857300_B25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182a6f43a","article-title":"Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective","volume":"259","author":"Brauckhoff","year":"2014","journal-title":"Ann Surg"},{"issue":"6","key":"2019041123160857300_B26","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/jc.2016-3640","article-title":"Risk profile of the RET A883F germline mutation: an international collaborative study","volume":"102","author":"Mathiesen","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123160857300_B27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/thy.2010.0328","article-title":"Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation","volume":"21","author":"Jasim","year":"2011","journal-title":"Thyroid"},{"issue":"7","key":"2019041123160857300_B28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1089\/thy.2013.0620","article-title":"Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations","volume":"24","author":"Rich","year":"2014","journal-title":"Thyroid"},{"issue":"1","key":"2019041123160857300_B29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1677\/ERC-08-0096","article-title":"Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10","volume":"16","author":"Machens","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2019041123160857300_B30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/humu.21385","article-title":"Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10","volume":"32","author":"Frank-Raue","year":"2011","journal-title":"Hum Mutat"},{"issue":"1-2","key":"2019041123160857300_B31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.01.012","article-title":"Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC","volume":"322","author":"Frank-Raue","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"2019041123160857300_B32","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2007-1005","article-title":"RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center","volume":"92","author":"Elisei","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041123160857300_B33","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/thy.2015.0673","article-title":"A nationwide study of multiple endocrine neoplasia type 2a in Norway: predictive and prognostic factors for the clinical course of medullary thyroid carcinoma","volume":"26","author":"Opsahl","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"2019041123160857300_B34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/thy.2014.0277","article-title":"Response to initial therapy predicts clinical outcomes in medullary thyroid cancer","volume":"25","author":"Lindsey","year":"2015","journal-title":"Thyroid"},{"key":"2019041123160857300_B35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-319-22542-5_10","article-title":"Long-term follow-up in medullary thyroid carcinoma","volume":"204","author":"Raue","year":"2015","journal-title":"Recent Results Cancer Res"},{"issue":"20","key":"2019041123160857300_B36","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1158\/1078-0432.CCR-16-0484","article-title":"Thyroid cancer: risk-stratified management and individualized therapy","volume":"22","author":"Raue","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2019041123160857300_B37","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa043999","article-title":"Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A","volume":"353","author":"Skinner","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"2019041123160857300_B38","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00268-009-0370-2","article-title":"Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study","volume":"34","author":"Schreinemakers","year":"2010","journal-title":"World J Surg"},{"issue":"11","key":"2019041123160857300_B39","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1210\/jc.2005-0044","article-title":"Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma","volume":"90","author":"Barbet","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123160857300_B40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-07-0667","article-title":"Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times","volume":"158","author":"Laure Giraudet","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019041123160857300_B41","doi-asserted-by":"crossref","first-page":"E286","DOI":"10.1210\/jc.2013-3343","article-title":"Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutations","volume":"99","author":"Machens","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019041123160857300_B42","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2017-00317","article-title":"Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness","volume":"102","author":"Voss","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041123160857300_B43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/jc.2017-01884","article-title":"Long-term survivorship in multiple endocrine neoplasia type 2B diagnosed before and in the new millennium","volume":"103","author":"Raue","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041123160857300_B44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.surg.2016.04.053","article-title":"Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30\u00a0years","volume":"161","author":"Randle","year":"2017","journal-title":"Surgery"},{"issue":"6","key":"2019041123160857300_B45","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2265.2006.02659.x","article-title":"Determinants of life expectancy in medullary thyroid cancer: age does not matter","volume":"65","author":"de Groot","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2019041123160857300_B46","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"issue":"5","key":"2019041123160857300_B47","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004230050143","article-title":"German MTC\/MEN Study Group. Medullary thyroid carcinoma\/multiple endocrine neoplasia type 2","volume":"383","author":"Raue","year":"1998","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"2019041123160857300_B48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrendo.2016.11","article-title":"A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma","volume":"12","author":"Romei","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2019041123160857300_B49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrc3680","article-title":"RET revisited: expanding the oncogenic portfolio","volume":"14","author":"Mulligan","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2019041123160857300_B50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1097-0215(20010120)95:1<62::AID-IJC1011>3.0.CO;2-1","article-title":"Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma","volume":"95","author":"Schilling","year":"2001","journal-title":"Int J Cancer"},{"issue":"3","key":"2019041123160857300_B51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jc.2007-1714","article-title":"Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study","volume":"93","author":"Elisei","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041123160857300_B52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/thy.2011.0358","article-title":"Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer","volume":"22","author":"Romei","year":"2012","journal-title":"Thyroid"},{"issue":"2","key":"2019041123160857300_B53","doi-asserted-by":"crossref","first-page":"E364","DOI":"10.1210\/jc.2012-2703","article-title":"Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS","volume":"98","author":"Agrawal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041123160857300_B54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/ERC-18-0056","article-title":"Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis","volume":"25","author":"Vuong","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"2019041123160857300_B55","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1089\/thy.2017.0113","article-title":"Reduced retinoblastoma protein expression is associated with decreased patient survival in medullary thyroid cancer","volume":"27","author":"Valenciaga","year":"2017","journal-title":"Thyroid"},{"issue":"2","key":"2019041123160857300_B56","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12020-014-0204-3","article-title":"Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation","volume":"47","author":"Puppin","year":"2014","journal-title":"Endocrine"},{"issue":"1","key":"2019041123160857300_B57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/thy.2012.0207","article-title":"Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series","volume":"23","author":"Ciampi","year":"2013","journal-title":"Thyroid"},{"issue":"14","key":"2019041123160857300_B58","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1158\/1078-0432.CCR-11-0242","article-title":"MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets","volume":"17","author":"Abraham","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2019041123160857300_B59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12943-016-0563-x","article-title":"MiR-182 promotes cancer invasion by linking RET oncogene activated NF-\u03baB to loss of the HES1\/Notch1 regulatory circuit","volume":"16","author":"Spitschak","year":"2017","journal-title":"Mol Cancer"},{"issue":"1","key":"2019041123160857300_B60","doi-asserted-by":"crossref","first-page":"42074","DOI":"10.1038\/srep42074","article-title":"Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations","volume":"7","author":"Oczko-Wojciechowska","year":"2017","journal-title":"Sci Rep"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/2\/8\/933\/25249262\/js.2018-00178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T14:18:40Z","timestamp":1555078720000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/2\/8\/933\/5052775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,7,13]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2018-00178","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,7,13]]}}}